berotek has been researched along with Cyanosis in 1 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
Cyanosis: A bluish or purplish discoloration of the skin and mucous membranes due to an increase in the amount of deoxygenated hemoglobin in the blood or a structural defect in the hemoglobin molecule.
Excerpt | Relevance | Reference |
---|---|---|
" These findings, however, cannot prove with certainty the cardiotoxic effect of Fenoterol on the myocardium, but it appears possible that an especially high dosage of Fenoterol given i." | 1.26 | [Newborn cardiotoxicity after tocolysis with fenoterolhydrobromide]. ( Schmidt-Redemann, B; Urbanek, R; Vogt, J, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vogt, J | 1 |
Schmidt-Redemann, B | 1 |
Urbanek, R | 1 |
1 other study available for berotek and Cyanosis
Article | Year |
---|---|
[Newborn cardiotoxicity after tocolysis with fenoterolhydrobromide].
Topics: Acidosis; Cyanosis; Ethanolamines; Female; Fenoterol; Heart Diseases; Heart Failure; Humans; Infant, | 1979 |